Effiectiveness and safety of MRI based 'frameless' stereotactic biopsy of brain tumours
More details
Hide details
Oddział Neurochirurgii, Wojewódzki Szpital Specjalistyczny nr 2 w Jastrzębiu-Zdroju
Katedra i Zakład Fizjologii Wydziału Lekarskiego w Katowicach, Śląski Uniwersytet Medyczny w Katowicach
Paweł Chodakowski   

Oddział Neurochirurgii, Wojewódzki Szpital Specjalistyczny nr 2 w Jastrzębiu-Zdroju, Al. Jana Pawła II 7, 44-330 Jastrzębie-Zdrój, tel. +48 792 840 620; fax: +48 792 840 620
Ann. Acad. Med. Siles. 2016;70:122–126
Stereotactic biopsy is a relatively commonly used tool for brain tumour diagnostics. A frame-based stereotactic biopsy is the standard, but the so-called 'frameless' biopsy, which is done by using a special neuronavigation system, seems to be a safe and convenient alternative. The authors have assessed the safety and effectiveness of an MRI based 'frameless' stereotactic biopsy of brain tumours.

Material and methods:
42 cases of patients, who underwent 'frameless' brain tumour biopsies in 2011–2013, were been retrospectively analysed. The biopsies were done by using BrainLab™ neuronavigation with VarioGuide and biopsy side-cut needles. The operation plan was based on a preoperative MRI head. In every case, at least 3 specimens various trajectories were taken. Pathological analysis was performed in the same place in every case.

There were 85.7% cases with an exact histopathological result. 14.3% cases obtained a pathological result, but without exact diagnosis. One patient (2.4%) with astrocytoma WHO III died as a result of a perioperative intra-ventricular hemorrhage. Other clinically significant perioperative complications occurred in 2 cases (4.8%). The histopathological diagnostics revealed: 12 cases of GBM (28.6%), 8 cases of astrocytoma WHO III (19%), 10 cases of astrocytoma WHO II (23.8%), 1 case of metastasis (2.4%), 1 case of lymphoma (2.4%) as well as 2 other lesions (4.8%). Statistical analysis revealed no significant differences in the patients’ pre- and postoperative state.

The 'frameless' biopsy is an effective and relatively safe way of diagnosing brain tumours. This type of biopsy takes less time to perform. It seems that it can be recommended as a convenient alternative to frame-based biopsy.

Woodworth G., McGirt M.J., Samdani A., Garonzik I., Olivi A., Weingart J.D. Accuracy of frameless and frame-based image-guided stereotactic brain biopsy in the diagnosis of glioma: comparison of biopsy and open resection specimen. Neurol. Res. 2005; 27(4): 358–362.
Nishihara M., Takeda N., Harada T. i wsp. Diagnostic yield and morbidity by neuronavigation‐guided frameless stereotactic biopsy using magnetic resonance imaging and by frame‐based computed tomography‐guided stereotactic biopsy. Surg. Neurol. Int. 2014; 5(Suppl. 8): 421–S426.
Amin D.V., Lozanne K., Parry P.V., Engh J.A., Seelman K., Mintz A. Image-guided frameless stereotactic needle biopsy in awake patients without the use of rigid head fixation. J. Neurosurg. 2011; 114: 1414–1420.
Apuzzo M.L., Chandrasoma P.T., Cohen D., Zee C.S,. Zelman V. Computed imaging stereotaxy: Experience and perspective related to 500 procedures applied to brain masses. Neurosurgery 1987; 20: 930–937.
Apuzzo M.L., Sabshin J.K. Computed tomographic guidance stereotaxis in the management of intracranial mass lesions. Neurosurgery 1983; 12(3): 277–285.
Dammers R., Haitsma I.K., Schouten J.W., Kros J.M., Avezaat C.J., Vincent A.J. Safety and efficacy of frameless and frame‐based intracranial biopsy techniques. Acta Neurochir. (Wien) 2008; 150(1): 23–29.
Dorward N.L., Paleologos T.S., Alberti O., Thomas D.G. The advantages of frameless stereotactic biopsy over frame-based biopsy. Br. J. Neurosurg. 2002; 16: 110–118.
Gralla J., Nimsky C., Buchfelder M., Fahlbusch R., Ganslandt O. Frameless stereotactic brain biopsy procedures using the Stealth Station: Indications, accuracy and results. Zentralbl. Neurochir. 2003; 64: 166–170.
Tanei T., Takebayashi S., Nakahara N., Nagatani T., Wakabayashi T. Biopsy of brain parenchymal lesions: procedure selection and ingenuity of accurate and safety biopsy. No Shinkei Geka. 2014; 42(9): 837–840.
Grossman R., Sadetzki S., Spiegelmann R., Ram Z. Haemorrhagic complications and the incidence of asymptomatic bleeding associated with stereotactic brain biopsies. Acta Neurochir. (Wien) 2005; 147: 627–631.
Lunsford L.D., Niranjan A., Khan A.A., Kondziolka D. Establishing a benchmark for complications using frame-based stereotactic surgery. Stereotact. Funct. Neurosurg. 2008; 86: 278–287.
Kongkham P.N., Knifed E., Tamber M.S., Bernstein M. Complications in 622 cases of frame-based stereotactic biopsy, a decreasing procedure. Can. J. Neurol. Sci. 2008; 35: 79–84.
McGirt M.J., Woodworth G.F., Coon A.L. Independent predictors of morbidity after image-guided stereotactic brain biopsy: A risk assessment of 270 cases. J. Neurosurg. 2005; 102: 897–901.
Paleologos T.S., Dorward N.L., Wadley J.P., Thomas D.G. Clinical validation of true frameless stereotactic biopsy: Analysis of the first 125 consecutive cases. Neurosurgery 2001; 49: 830–835.
Heper A.O., Erden E., Savas A. An analysis of stereotactic biopsy of brain tumors and nonneoplastic lesions: A prospective clinicopathologic study. Surg. Neurol. 2005; 64 (Suppl. 2): S82–S88.
Gempt J., Buchmann N., Ryang Y.M. Frameless image-guided stereotaxy with real-time visual feedbeck for brain biopsy. Acta Neurochir. (Wien) 2012; 154(9): 1663–1667.
Wen D.Y., Hall W.A., Miller D.A., Seljeskog E.L., Maxwell R.E. Targeted brain biopsy: a comparison of freehand computed to – mography – guided and stereotactic techniques. Neurosurgery 1993; 32: 407–412.
Barnett G.H., Miller D.W., Weisenberger J. Frameless stereotaxy with scalp-applied fiducial markers for brain biopsy procedures: experience in 218 cases. J. Neurosurg. 1999; 91: 569–576.
Germano I.M., Queenan J.V. Clinical experience with intracranial brain needle biopsy using frameless surgical navigation. Comput. Aided. Surg. 1998; 3: 33–39.
Hall W.A. The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer 1998; 82: 1749–1755.